⌘K

Login Start Free

Home/Filings/4/0001209191-14-076018

4//SEC Filing

Oncothyreon Inc. 4

Accession 0001209191-14-076018

CIK 0001412067operating

View on SEC.gov Company Profile

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 7:19 PM ET

Size

5.6 KB

Accession

0001209191-14-076018

Insider Transaction Report

Form 4

Period: 2014-12-16

Oncothyreon Inc.ONTY

KIRKMAN ROBERT L

DirectorPresident/CEO

Transactions

Award
Stock Option (right to buy)
2014-12-16+300,000→ 300,000 total
Exercise: $1.76Exp: 2022-12-16→ Common Stock (300,000 underlying)

Footnotes (1)

[F1]The option vests and is exercisable at the rate of 1/4th of the total shares on December 16, 2015 and then 1/48th of the total shares vest and are exercisable monthly thereafter, with 100% vested and exercisable on December 16, 2018.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Oncothyreon Inc.

CIK 0001412067

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001412067

Filing Metadata

Form type: 4
Filed: Dec 15, 7:00 PM ET
Accepted: Dec 16, 7:19 PM ET
Size: 5.6 KB

View on SEC.gov